Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenomics, Power3 Create CRO to Sell Power3's Protein Dxs

NEW YORK (GenomeWeb News) — NeoGenomics and Power3 Medical Products have formed a joint venture to create a contract research organization to sell Power3’s protein biomarker-based diagnostics, NeoGenomics said today.
Under the agreement, NeoGenomics has non-exclusively licensed all of Power3’s intellectual property for protein biomarkers. The diagnostics the companies plan to market will be based on “one or more” of these markers, NeoGenomics said.
NeoGenomics also will supply the organization with “access to cancer samples, management, sales and marketing personnel, laboratory facilities,” and $200,000 in working capital and a convertible debenture.
NeoGenomics also will receive two options to increase its stake in Power3 over the next 18 to 20 months.   
NeoGenomics President and CSO Robert Gasparini said Power3’s emphasis on breast cancer diagnostics fits with NeoGenomics’ “strategic interests.”
The company said it expects the CRO to start operating before the end of the year.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.